Literature DB >> 18471551

Evaluation and management of end-stage liver disease in children.

Mike A Leonis1, William F Balistreri.   

Abstract

End-stage liver disease in children presents a challenging array of medical and psychosocial problems for the health care delivery team. Many of these problems are similar to those encountered by caregivers of adults with end-stage liver disease, such as the development of complications of cirrhosis, including ascites, spontaneous bacterial peritonitis, and esophageal variceal hemorrhage. However, the natural history of disease progression in children and their responses to medical therapy can differ significantly from that of their adult counterparts. Children with end-stage liver disease are especially vulnerable to nutritional compromise; if not effectively managed, this can seriously impact long-term outcomes and survival both before and after liver transplantation. Moreover, close attention must be given to vaccination status and the clinical setting at which health care is delivered to optimize outcomes and the delivery of high-quality pediatric health care. In this review, we address important components of the evaluation and management of children with chronic end-stage liver disease.

Entities:  

Mesh:

Year:  2008        PMID: 18471551     DOI: 10.1053/j.gastro.2008.02.029

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  13 in total

Review 1.  Cirrhosis in children and adolescents: An overview.

Authors:  Raquel Borges Pinto; Ana Claudia Reis Schneider; Themis Reverbel da Silveira
Journal:  World J Hepatol       Date:  2015-03-27

Review 2.  Transient elastography for assessment of fibrosis in paediatric liver disease.

Authors:  Valerio Nobili; Lidia Monti; Anna Alisi; Cristina Lo Zupone; Andrea Pietrobattista; Paolo Tomà
Journal:  Pediatr Radiol       Date:  2011-06-16

Review 3.  Paediatric chronic liver diseases: how to investigate and follow up? Role of imaging in the diagnosis of fibrosis.

Authors:  Danièle Pariente; Stéphanie Franchi-Abella
Journal:  Pediatr Radiol       Date:  2010-04-30

Review 4.  Coagulopathy and transfusion therapy in pediatric liver transplantation.

Authors:  Mirco Nacoti; Davide Corbella; Francesco Fazzi; Francesca Rapido; Ezio Bonanomi
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

Review 5.  Medical management of chronic liver diseases (CLD) in children (part II): focus on the complications of CLD, and CLD that require special considerations.

Authors:  Mortada H F El-Shabrawi; Naglaa M Kamal
Journal:  Paediatr Drugs       Date:  2011-12-01       Impact factor: 3.022

6.  Liver cirrhosis in children - the role of imaging in the diagnostic pathway.

Authors:  Jochen Herrmann; Philippe Petit; Enke Grabhorn; Alexander Lenz; Julian Jürgens; Stéphanie Franchi-Albella
Journal:  Pediatr Radiol       Date:  2022-08-30

7.  Impact of the Pediatric End-Stage Liver Disease (PELD) growth failure thresholds on mortality among pediatric liver transplant candidates.

Authors:  Sonja M Swenson; John P Roberts; Sue Rhee; Emily R Perito
Journal:  Am J Transplant       Date:  2019-09-03       Impact factor: 8.086

Review 8.  Caring for adults with pediatric liver disease.

Authors:  Michelle Rook; Philip Rosenthal
Journal:  Curr Gastroenterol Rep       Date:  2009-02

9.  Relationship between biopsy-proven parenteralnutrition-associated liver fibrosis and biochemical cholestasis in children with short bowel syndrome.

Authors:  Shimae C Fitzgibbons; Brian A Jones; Melissa A Hull; David Zurakowski; Debora Duro; Christopher Duggan; Dana Boctor; David L Sigalet; Tom Jaksic
Journal:  J Pediatr Surg       Date:  2010-01       Impact factor: 2.545

Review 10.  Advances in management of end stage liver disease in children.

Authors:  Aradhana Aneja; Elizabeth Scott; Rohit Kohli
Journal:  Med J Armed Forces India       Date:  2021-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.